Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9876
CALL
Virco
VIRC
$95.3M
| $264K | ﹤0.01% |
25,800
+5,300
| +26% | +$74.3K |
|
9877
Cadiz
CDZI
$274M
| $264K | ﹤0.01% |
50,846
+48,250
| +1,859% | +$174K |
|
9878
Navigator Holdings
NVGS
$1.32B
| $264K | ﹤0.01% |
17,215
-194,061
| -92% | -$3.05M |
|
9879
MIND Technology
MIND
$48M
| $264K | ﹤0.01% |
+33,268
| New | +$150K |
|
9880
CALL
VOC Energy
VOC
$55.4M
| $263K | ﹤0.01% |
55,100
+20,300
| +58% | +$102K |
|
9881
PUT
Airgain
AIRG
$71.4M
| $263K | ﹤0.01% |
37,300
+25,800
| +224% | +$226K |
|
9882
PUT
Stewart Information Services
STC
$2.07B
| $263K | ﹤0.01% |
3,900
+3,400
| +680% | +$243K |
|
9883
CALL
A10 Networks
ATEN
$1.99B
| $263K | ﹤0.01% |
14,300
+1,200
| +9% | +$19.6K |
|
9884
CALL
Cullinan Oncology
CGEM
$1.35B
| $263K | ﹤0.01% |
21,600
-19,000
| -47% | -$273K |
|
|
MPX
9885
DELISTED
Marine Products Corp
MPX
| $263K | ﹤0.01% |
28,682
-1,227
| -4% | -$11.8K |
|
9886
PUT
ClearPoint Neuro
CLPT
$474M
| $263K | ﹤0.01% |
17,100
-9,000
| -34% | -$117K |
|
9887
SRH REIT Covered Call ETF
SRHR
$53.1M
| $263K | ﹤0.01% |
4,589
-12,316
| -73% | -$738K |
|
9888
Innovator International Developed Power Buffer ETF October
IOCT
$169M
| $263K | ﹤0.01% |
8,967
-3,864
| -30% | -$115K |
|
9889
CALL
U-Haul Holding Co Series N
UHAL.B
$12.6B
| $263K | ﹤0.01% |
+4,100
| New | +$270K |
|
9890
Lifetime Brands
LCUT
$218M
| $263K | ﹤0.01% |
44,423
-61,921
| -58% | -$374K |
|
9891
CALL
Citi Trends
CTRN
$606M
| $263K | ﹤0.01% |
10,000
-1,600
| -14% | -$33.7K |
|
9892
HealthStream
HSTM
$826M
| $262K | ﹤0.01% |
8,254
-22,431
| -73% | -$692K |
|
9893
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.87B
| $262K | ﹤0.01% |
2,098
-7,704
| -79% | -$987K |
|
9894
PUT
Atlas Lithium Corp
ATLX
$92.3M
| $262K | ﹤0.01% |
41,400
+9,400
| +29% | +$71.6K |
|
9895
iShares MSCI Europe Small-Cap ETF
IEUS
$184M
| $262K | ﹤0.01% |
+4,884
| New | +$275K |
|
9896
KNOT Offshore Partners
KNOP
$366M
| $262K | ﹤0.01% |
48,070
+536
| +1% | +$3.24K |
|
9897
PUT
Cass Information Systems
CASS
$738M
| $262K | ﹤0.01% |
6,400
+1,300
| +25% | +$55.8K |
|
9898
CALL
Standex International
SXI
$3.95B
| $262K | ﹤0.01% |
1,400
-2,300
| -62% | -$444K |
|
|
VIRX
9899
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $262K | ﹤0.01% |
1,626,258
+106,018
| +7% | +$20.9K |
|
9900
VanEck Moody's Analytics IG Corporate Bond ETF
MIG
$19.8M
| $261K | ﹤0.01% |
12,395
+524
| +4% | +$11.3K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.